Harrow Inc (HROW)
43.93
+1.49
(+3.51%)
USD |
NASDAQ |
Nov 21, 16:00
43.58
-0.35
(-0.80%)
After-Hours: 19:17
Harrow Price: 43.93 for Nov. 21, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 20, 2024 | 40.03 | 42.52 | 39.85 | 42.44 | 585650.0 |
Nov 19, 2024 | 37.25 | 39.96 | 37.08 | 39.70 | 488857.0 |
Nov 18, 2024 | 40.06 | 40.06 | 37.00 | 37.97 | 1.103M |
Nov 15, 2024 | 42.94 | 42.94 | 38.35 | 39.01 | 1.348M |
Nov 14, 2024 | 41.75 | 46.32 | 38.96 | 42.86 | 2.464M |
Nov 13, 2024 | 50.07 | 54.19 | 50.00 | 51.80 | 1.059M |
Nov 12, 2024 | 52.50 | 53.88 | 48.67 | 49.91 | 725350.0 |
Nov 11, 2024 | 53.42 | 53.99 | 51.64 | 52.02 | 432563.0 |
Nov 08, 2024 | 49.69 | 53.00 | 49.68 | 52.51 | 467677.0 |
Nov 07, 2024 | 48.86 | 50.25 | 48.25 | 49.91 | 579013.0 |
Nov 06, 2024 | 47.45 | 48.58 | 46.27 | 48.24 | 400230.0 |
Nov 05, 2024 | 45.33 | 46.55 | 44.91 | 45.80 | 320528.0 |
Nov 04, 2024 | 45.63 | 47.02 | 44.75 | 45.83 | 364698.0 |
Nov 01, 2024 | 45.45 | 46.50 | 44.99 | 45.64 | 462988.0 |
Oct 31, 2024 | 44.50 | 45.31 | 43.59 | 45.06 | 442145.0 |
Oct 30, 2024 | 46.05 | 46.10 | 44.18 | 44.42 | 513134.0 |
Oct 29, 2024 | 46.91 | 47.14 | 45.31 | 46.55 | 594425.0 |
Oct 28, 2024 | 51.66 | 51.91 | 46.19 | 47.20 | 1.070M |
Oct 25, 2024 | 53.90 | 53.99 | 50.56 | 50.60 | 556357.0 |
Oct 24, 2024 | 54.77 | 55.75 | 52.59 | 53.04 | 438715.0 |
Oct 23, 2024 | 56.76 | 57.11 | 52.00 | 54.22 | 642031.0 |
Oct 22, 2024 | 56.50 | 57.72 | 55.57 | 56.98 | 425538.0 |
Oct 21, 2024 | 57.44 | 57.48 | 55.87 | 56.42 | 625548.0 |
Oct 18, 2024 | 56.18 | 59.23 | 56.01 | 57.48 | 558917.0 |
Oct 17, 2024 | 54.99 | 57.20 | 54.99 | 56.41 | 462430.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
3.50
Minimum
Mar 23 2020
57.48
Maximum
Oct 18 2024
12.64
Average
9.295
Median
Price Benchmarks
Calidi Biotherapeutics Inc | 2.155 |
NovaBay Pharmaceuticals Inc | 0.718 |
Palatin Technologies Inc | 0.91 |
iBio Inc | 2.45 |
Theriva Biologics Inc | 1.28 |
Price Related Metrics
PS Ratio | 9.233 |
PEG Ratio | -0.4162 |
Price to Book Value | 26.99 |
Price to Free Cash Flow | 528.27 |
Earnings Yield | -2.16% |
Market Cap | 1.565B |
PEGY Ratio | -0.4162 |